Zachary R. Lavender, PA-C, MHS; Peter S. Sandor, RRT, MHS, PA-C, DFAAPA

All articles by Zachary R. Lavender, PA-C, MHS; Peter S. Sandor, RRT, MHS, PA-C, DFAAPA

May 3, 2018

Advances in new reversal agents will be key for managing patients treated with DOACs to prevent major bleeding events.

Next post in Features